Joseph T. Vazzana
<p><em> </em></p>
<p><em> </em></p>
<p>Dr. Tokayer received his B.A. in from Yeshiva College and his M.D. from Albert Einstein College of Medicine of Yeshiva University. He completed an internship and residency at the Bronx Municipal Hospital Center and GI and Hepatology fellowship at Johns Hopkins Medical Center. He received an MHS degree in Clinical Epidemiology from Johns Hopkins School of Public Health. Dr. Tokayer then joined the Montefiore GI Faculty in 1992. He has been involved in the spectrum of clinical patient care, endoscopic interventions and teaching in the GI fellowship program. His areas of interest include clinical practice, patient care and education, endoscopic procedures and interventions, functional GI and motility disorders. He is Director of the GI Motility Lab where studies such as Esophageal Manometry, Esophageal Acid Monitoring and Impedance Testing, Ano-rectal Manometry and Defecatory Testing, Hydrogen Breath Testing for Bacterial overgrowth and Carbohydrate Maldigestion , and studies of gastric and intestinal transit. He works closely with colleagues of the Department of Radiology and Nuclear Medicine as well as the Department of Surgery in diagnosing and treating GI motility disorders.</p>
Dr. Shapiro’s clinical focus is on hernia repairs and the gastrointestinal tract, utilizing state-of-the-art minimally invasive surgery techniques to provide optimal care.
Dr. Shapiro’s research focuses on hernia repair.
<p>Kenneth Shapiro, MD, FACS, is an attending surgeon and Assistant Professor, Surgery at Montefiore Einstein. Dr. Shapiro’s clinical focus is on hernia repairs and the gastrointestinal tract, utilizing state-of-the-art minimally invasive surgery techniques to provide optimal care. He is proud to have served the Bronx community for his entire career.</p><p>In 1994, Dr. Shapiro graduated from The Sophie Davis School of Biomedicine, receiving his Bachelor of Science in biomedicine. He later attended New York Medical College, earning his Doctor of Medicine in 1996. After several months of clinical research with the Mount Sinai/Cabrini program, Dr. Shapiro pursued his surgery residency at Cabrini Medical Center, completing it in 2002. In 2003, he completed his minimally invasive surgery fellowship at Staten Island University.</p><p>Dr. Shapiro’s research focuses on hernia repair. He has shared his work through publication in peer-reviewed journals and oral and poster presentations.</p><p>Dr. Shapiro is board certified by the American Board of Surgeons. He is a Fellow of the American College of Surgeons and a member of several professional organizations including the Society for Surgery of the Alimentary Tract and the Society of Laparoscopic Surgeons.</p>
<p>Jonathan M. Schwartz is a board Certified Transplant Hepatologist. He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle. He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University.</p>
<p>Dr. Schwartz has an interest in treating patients with acute and chronic liver diseases including those patients with advanced liver diseases who require liver transplantation.</p>
<p>He has a special interest in the multidisciplinary care of patients with liver tumors.</p>
<p><strong><br /></strong></p>
<ul>
<li>Estes JD, Stolpman D, Olyaei A, Ham JM, <strong>Schwartz JM</strong>, Orloff SL. High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Fulminant Hepatic Failure Patients. Arch Surg. 2003;138(8):852-8.</li>
<li><strong>Schwartz JM</strong>, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman D, Kowdley KV. Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts: Role of Increased Pulmonary Artery Pressure. J Clin Gastroenterol 2004;38(7):590-594.</li>
<li>Lim LL, Scarborough J, Thorne J, Graham E, Kempen J, Mackensen F, Nguyen Q D, Prabriputaloong T, Read R, Suhler EB, <strong>Schwartz JM</strong>, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;147(2):332-338.</li>
<li>O’Glasser AY, Scott DA, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, and <strong>Schwartz JM.</strong>Hepatic and Cardiac Iron Overload Among Patients with End-Stage Liver Disease Referred for Liver Transplantation. Clinical Transplantation. Clin Transplant. 2010 Sep-Oct;24(5):643-51.</li>
<li>Kanwal F, Befeler A, Chari R, Marrero J, Kahn J, Afdhal N, Morgan T, Roberts L, Mohanty SR, <strong>Schwartz J</strong>, Van Thiel D, Hassanein TI, Li J, Zeringue A, DiBisceglie A. Rate of Potentially Curative Treatment in Patients with Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2012 Aug;36(3):257-65.</li>
<li>Bichoupan K1, <strong>Schwartz JM,</strong> Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H,Dieterich DT, Branch AD, Reinus JF. Effect of Fibrosis on Adverse Events in Patients with Hepatitis C Treated with Telaprevir. Aliment Pharmacol Ther. 2014;39(2):209-16.</li>
<li><strong>Schwartz J</strong> and Carithers RL. Epidemiology and Etiologic Associations of Primary Hepatocellular Carcinoma. In Rose BD, editor. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li><strong>Schwartz JM </strong>and Carithers RL, Jr. Clinical features, diagnosis, and screening for primary hepatocellular carcinoma. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Curley SA, Stewart KE, <strong>Schwartz JM</strong>, Carthers RL, Jr. Nonsurgical therapies for localized hepatocellular carcinoma. Up to date, Inc. Wellesley, MA, Updated 2014.<strong> </strong></li>
<li><strong>Schwartz JM</strong>. Approach to the patient with a focal liver lesion. Up to date Inc Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Hartwell L and <strong>Schwartz JM. </strong>AsymptomaticLiver Chemistry Abnormalities. Journal of Clinical Outcomes Management. 2009; 16 (11): 525-34.</li>
<li>Urquhart J<strong>, Schwartz, JM.</strong> Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports, 2011.</li>
<li><strong>Schwartz, JM </strong>and Reinus JF. Prevalence and Natural History of Alcoholic Liver Disease. Clinics in Liver Disease. 2012; 16 (4): 659-66.</li>
</ul>
<p> </p>
<p>Dr. Frager specializes in disorders of the Colon and Upper GI Tract including: Colon Polyps, Diverticulitis, Peptic Ulcer Disease, Gastroesophageal Reflux and Gallstones.</p>
<p>Immunology of the GI Tract</p>
<p>Joseph Frager, MD, is an Attending Physician in Gastroenterology and Assistant Professor of Medicine at Montefiore Einstein. Dr. Frager specializes in the diagnosis and treatment of disorders of the colon and upper gastrointestinal tract including colon polyps, diverticulitis, peptic ulcer disease, gastroesophageal reflux and gallstones.</p><p>After earning his Doctor of Medicine from University of Pennsylvania School of Medicine in 1980, Dr. Frager came to Montefiore for his postgraduate training. He completed his internal medicine internship and residency in 1983, followed by his fellowship in gastroenterology in 1985.</p><p>Dr. Frager’s research focus is on the immunology of the gastrointestinal tract. He has shared his work through peer-reviewed journals and abstracts.</p><p>Dr. Frager is board certified in Internal Medicine by the American Board of Internal Medicine. He is a member of the American College of Gastroenterology, the American Gastroenterology Association and the New York Society for Gastrointestinal Endoscopy.</p>
<p>Single-Incision Laparoscopic Surgery, <a href="https://www.montefiore.org/surgery-services-general-weight-reduction-ce… Surgery</a>, <a href="https://www.montefiore.org/montefiore-institute-for-minimally-invasive-… Invasive Surgery</a></p>
With high rates of obesity and diabetes in the Bronx, Dr. Choi sees many opportunities to evaluate the long-term benefits of bariatric surgery in this population.
<p>Francis B. Baccay, MD, is an attending surgeon at Montefiore Einstein and Associate Professor, Surgery at our Albert Einstein College of Medicine. Dr. Baccay’s clinical focus centers on general and acute care surgery.</p><p>After obtaining his Bachelor of Science in biology and Bachelor of Arts in sociology from Tulane University in 1989, Dr. Baccay earned his Doctor of Medicine from New York Medical College in 1993. He then completed his general surgery internship in 1994 and his general surgery residency in 2000 at New York Medical College/Westchester Medical Center. Dr. Baccay remained at this institution to complete a trauma and surgical critical care fellowship in 2001.</p><p>Dr. Baccay’s research focuses on surgical education curriculum design and assessment. His work has been shared through numerous peer-reviewed publications and oral and poster presentations. He is on the peer review board of the American College of Surgeons, where he is a submissions reviewer for the <em>Journal of the American College of Surgeons</em>. He is also on the peer review board for the Association of American Medical Colleges, where he is a submissions reviewer for MedEd Portal Publications and the Northeast Group on Education Affairs.</p><p>Dr. Baccay is board certified by the American Board of Surgery. He is a member of the Society of American Gastrointestinal and Endoscopic Surgeons, the Association of Surgical Education and the American College of Surgeons. Dr. Baccay received the Samuel Rosen Excellence in Clinical Teaching Award in 2018 and the Harry H. Gordon Award for Outstanding Clinical Teaching in 2024 from Montefiore Einstein. He has also won the Patients’ Choice Award from the Greater New York Patient Survey for multiple years.</p>